Outcomes
diabetes
DIABETES
The key primary outcome was time to optimal insulin dose, measured as the number of days between the study start date and the date that the goal 3-day mean FBG level was achieved. Other primary outcomes were mean insulin adherence based on logged data and change in the composite scores of the 3 surveys measuring attitudes toward diabetes, health technology, and medication adherence. Secondary outcomes were glycemic control and glycemic improvement. Glycemic control was measured as the proportion of participants who had achieved the goal FBG level by 8 weeks. Glycemic improvement was measured as the change in 3-day mean FBG values from baseline to 8 weeks.